Interdisciplinary clinical target volume generation for cardiac radioablation: Multi-center benchmarking for the RAdiosurgery for VENtricular TAchycardia (RAVENTA) trial
Abstract
BACKGROUND
Cardiac radioablation is a novel treatment option for therapy-refractory ventricular tachycardia (VT) ineligible for catheter-ablation. Three-dimensional clinical target volume (CTV) definition is a key step and this complex interdisciplinary procedure includes VT-substrate identification based on electroanatomical mapping (EAM) and its transfer to the planning-CT (PCT). Benchmarking of this process is necessary for multi-center clinical studies such as the XXX trial.
METHODS
For benchmarking of the XXX-trial, patient data (epicrisis, ECG, high-resolution EAM, contrast-enhanced cardiac-CT, PCT) of three cases were sent to five university centers for independent CTV -generation, subsequent structure analysis and consensus finding. VT-substrates were first defined on multiple EAM screenshots/videos and manually transferred to the PCT. The generated structure characteristics were then independently analyzed (volume, localization, surface distance and conformity). After subsequent discussion, consensus structures were defined.
RESULTS
VT-substrate on the EAM showed visible variability in extent and localization for cases 1 and 2 and only minor variability for case 3. CTVs ranged between 6.7-22.9cm3, 5.9-79.9cm3 and 9.4-34.3cm3; surface area varied between 1087-3285mm2, 1077-9500mm2 and 1620-4179mm2, with a Hausdorff-distance between 15.7-39.5mm, 23.1-43.5mm and 15.9-43.9mm for case 1-3, respectively. The absolute 3D-center-of-mass difference was 5.8-28.0mm, 8.4-26mm…
Read the paper
Related studies
- Preliminary Toxicity Analysis of 3DCRT versus IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial
- Adaptive Radiotherapy for Head and Neck Cancer: Initial Clinical Outcomes from a Prospective Trial
- American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology
- Motion Management Strategies and Technical Issues Associated with Stereotactic Body Radiotherapy of Thoracic and Upper Abdominal Tumors: A Review from NRG Oncology
- High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial
- Highly efficient training, refinement, and validation of a knowledge-based plan quality control system for radiotherapy clinical trials
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.